Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Mapping for Endometrial Cancer

NCT01939028 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT01939028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01939028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Mapping for Endometrial Cancer
Lead sponsor
Case Comprehensive Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
July 31, 2013
Completion date
October 31, 2016
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage i endometrial carcinoma, stage ii endometrial carcinoma, stage iii endometrial carcinoma, stage iv endometrial carcinoma